Therefore, the aim of the present study was to investigate the potential anticancer effects of ADH‐1, as a known N‐cadherin antagonist, DTX, as the first line chemotherapy agent in PCa treatment, and Tel, as a novel small molecule, on cell viability, apoptosis, migration and cell attachment. The gene discussed is ADH1A; the disease is posterior cortical atrophy.